Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial

Tamaskovics, B. F. and Hecht, M. and Schubert, P. and Kallies, A. and Illmer, T. and Radke, J. and Koelbl, O. and Steger, F. and Brunner, T. B. and Roedel, C. and Fleischmann, M. and Reinacher-Schick, A. and Wingender, L. F. and Melchior, P. and Klautke, G. and Hintzen, U. and Gaipl, U. S. and Haussmann, J. and Budach, W. and Fietkau, R. (2023) Randomized phase II study of immune stimulation with pembrolizumab and radiotherapy of recurrent and/or metastatic head and neck squamous cell carcinoma : The IMPORTANCE trial. ANNALS OF ONCOLOGY, 34. S593-S593. ISSN 0923-7534, 1569-8041

Full text not available from this repository.

Item Type:	Article
Uncontrolled Keywords:	;
Subjects:	600 Technology > 610 Medical sciences Medicine
Divisions:	Medicine > Lehrstuhl für Strahlentherapie
Depositing User:	Dr. Gernot Deinzer
Date Deposited:	31 Jan 2024 09:33
Last Modified:	31 Jan 2024 09:33
URI:	https://pred.uni-regensburg.de/id/eprint/60423

Actions (login required)

View Item